Derrell Porter

Director/Board Member at PASSAGE BIO, INC.

Net worth: 101 175 $ as of 30/08/2026

55 year

61 connections

Health Technology

Consumer Services

Health Services

Profile

Dr. Derrell D.
Porter is an Independent Director at Acumen Pharmaceuticals, Inc., an Independent Director at Passage Bio, Inc. and a Chief Executive Officer & Director at CTRL Therapeutics, Inc. He is on the Board of Directors at Acumen Pharmaceuticals, Inc., Passage Bio, Inc., CTRL Therapeutics, Inc. and Biosortia Pharmaceuticals, Inc. Dr. Porter was previously employed as a Chief Executive Officer by Cellevolve Bio, Inc., a Senior Vice President & Global Head-Commercial by Atara Biotherapeutics, Inc., a Vice President by Gilead Sciences, Inc., a Sales Manager & Director-Corporate Development by AbbVie, Inc., and a Director-Corporate Development & Sales Manager by Amgen, Inc. He also served on the board at Alliance for Regenerative Medicine and Portal Innovations LLC.
He received his undergraduate degree from the University of California, Los Angeles, an MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from Perelman School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ACUMEN PHARMACEUTICALS, INC. 0.05%	16/06/2026	35,500 ( 0.05% )	101 175 $	30/08/2026
PASSAGE BIO, INC. -.--%	18/05/2026	0 ( -.--% )	- $	30/08/2026

Derrell Porter active positions

Companies	Position	Start
PASSAGE BIO, INC.	Director/Board Member	26/05/2021
ACUMEN PHARMACEUTICALS, INC.	Director/Board Member	03/01/2023
Biosortia Pharmaceuticals, Inc. Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of algal technologies with focus on concentration, dewatering, drying and extraction of biomass	Director/Board Member	-
CTRL Therapeutics, Inc. CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood	Chief Executive Officer	31/10/2023

All active positions of Derrell Porter

Former positions of Derrell Porter

Companies	Position	End
Cellevolve Bio Cellevolve Bio Pharmaceuticals: MajorHealth Technology Develops and commercializes cell therapies	Chief Executive Officer	31/10/2023
ATARA BIOTHERAPEUTICS, INC.	Corporate Officer/Principal	30/09/2019
GILEAD SCIENCES, INC.	Corporate Officer/Principal	30/04/2017
Portal Innovations LLC Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements.	Director/Board Member	-
Alliance for Regenerative Medicine Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine	Director/Board Member	-

See the detail of Derrell Porter's experience

Training of Derrell Porter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Derrell Porter's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Gilead Sciences, Inc. Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases	Health Technology
Acumen Pharmaceuticals, Inc. Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease	Health Technology
Biosortia Pharmaceuticals, Inc. Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of algal technologies with focus on concentration, dewatering, drying and extraction of biomass	Health Technology
AbbVie, Inc. AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies	Health Technology
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alliance for Regenerative Medicine Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine	Health Services
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Perelman School of Medicine Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases	Health Technology
Passage Bio, Inc. Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders	Health Technology
CTRL Therapeutics, Inc. CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood	Health Technology
Portal Innovations LLC Portal Innovations LLC Investment ManagersFinance Portal Innovations invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medtech and bioinformatics. It provides financing for seed and early stage capital requirements.	Finance
Cellevolve Bio Cellevolve Bio Pharmaceuticals: MajorHealth Technology Develops and commercializes cell therapies	Health Technology